Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Weight reduction in obese hypertensive patients.

Cohen MD, D'Amico FJ, Merenstein JH.

Fam Med. 1991 Jan;23(1):25-8.

PMID:
2001777
[PubMed - indexed for MEDLINE]
3.

Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension.

Davis BR, Blaufox MD, Oberman A, Wassertheil-Smoller S, Zimbaldi N, Cutler JA, Kirchner K, Langford HG.

Arch Intern Med. 1993 Aug 9;153(15):1773-82.

PMID:
8333814
[PubMed - indexed for MEDLINE]
4.

Orlistat in hypertensive overweight/obese patients: results of a randomized clinical trial.

Bloch KV, Salles GF, Muxfeldt ES, Da Rocha Nogueira A.

J Hypertens. 2003 Nov;21(11):2159-65.

PMID:
14597860
[PubMed - indexed for MEDLINE]
5.

Reductions of body weight and blood pressure in obese hypertensive patients treated by diet. A retrospective study.

Novi RF, Porta M, Lamberto M, Molinatti GM.

Panminerva Med. 1989 Jan-Mar;31(1):13-5.

PMID:
2726283
[PubMed - indexed for MEDLINE]
6.

[Dietetic-hygienic measures in the control of arterial hypertension in obese females].

Pecelj-Gec M, Jorga J, Marmut Z, Plećas D, Mirić G.

Srp Arh Celok Lek. 1992 Sep-Oct;120(9-10):273-5. Serbian.

PMID:
1306018
[PubMed - indexed for MEDLINE]
7.

Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial.

Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA.

J Hypertens. 2005 Jun;23(6):1241-9.

PMID:
15894901
[PubMed - indexed for MEDLINE]
8.

Blood pressure effects of antihypertensive drugs and changes in lifestyle in a Brazilian hypertensive cohort.

Fuchs FD, Gus M, Moreira WD, Moreira LB, Moraes RS, Rosito GA, Sorucco A, Atanázio P, Machado R.

J Hypertens. 1997 Jul;15(7):783-92.

PMID:
9222947
[PubMed - indexed for MEDLINE]
9.

Overweight, obesity, and blood pressure: the effects of modest weight reduction.

Mertens IL, Van Gaal LF.

Obes Res. 2000 May;8(3):270-8. Review.

PMID:
10832771
[PubMed - indexed for MEDLINE]
10.

The effect of weight loss intervention on antihypertensive medication requirements in the hypertension Optimal Treatment (HOT) study.

Jones DW, Miller ME, Wofford MR, Anderson DC Jr, Cameron ME, Willoughby DL, Adair CT, King NS.

Am J Hypertens. 1999 Dec;12(12 Pt 1-2):1175-80.

PMID:
10619579
[PubMed - indexed for MEDLINE]
11.

The effects of weight reduction on blood pressure in 301 obese patients.

Schotte DE, Stunkard AJ.

Arch Intern Med. 1990 Aug;150(8):1701-4.

PMID:
2383165
[PubMed - indexed for MEDLINE]
12.

Portion control plate for weight loss in obese patients with type 2 diabetes mellitus: a controlled clinical trial.

Pedersen SD, Kang J, Kline GA.

Arch Intern Med. 2007 Jun 25;167(12):1277-83.

PMID:
17592101
[PubMed - indexed for MEDLINE]
13.

Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study.

Scholze J, Grimm E, Herrmann D, Unger T, Kintscher U.

Circulation. 2007 Apr 17;115(15):1991-8. Epub 2007 Apr 2.

PMID:
17404163
[PubMed - indexed for MEDLINE]
Free Article
14.

The effect of gastric bypass surgery on hypertension in morbidly obese patients.

Carson JL, Ruddy ME, Duff AE, Holmes NJ, Cody RP, Brolin RE.

Arch Intern Med. 1994 Jan 24;154(2):193-200. Erratum in: Arch Intern Med 1994 Aug 8;154(15):1770.

PMID:
8285814
[PubMed - indexed for MEDLINE]
15.

Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients.

Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B.

N Engl J Med. 1978 Jan 5;298(1):1-6.

PMID:
337144
[PubMed - indexed for MEDLINE]
16.

Evaluation of a structured treatment and teaching programme on hypertension in general practice.

Mühlhauser I, Sawicki PT, Didjurgeit U, Jörgens V, Trampisch HJ, Berger M.

Clin Exp Hypertens. 1993 Jan;15(1):125-42.

PMID:
8467308
[PubMed - indexed for MEDLINE]
17.

Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.

McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K; Sibutramine in Hypertensives Clinical Study Group.

J Hum Hypertens. 2002 Jan;16(1):5-11.

PMID:
11840224
[PubMed - indexed for MEDLINE]
Free Article
18.

Failure of weight reduction to reduce mildly elevated blood pressure: a randomized trial.

Haynes RB, Harper AC, Costley SR, Johnston M, Logan AG, Flanagan PT, Sackett DL.

J Hypertens. 1984 Oct;2(5):535-9.

PMID:
6397541
[PubMed - indexed for MEDLINE]
19.

Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study.

Finer N, Bloom SR, Frost GS, Banks LM, Griffiths J.

Diabetes Obes Metab. 2000 Apr;2(2):105-12.

PMID:
11220522
[PubMed - indexed for MEDLINE]
20.

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.

J Hum Hypertens. 2002 Jan;16(1):13-9.

PMID:
11840225
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk